Credit Agricole’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $331K | Buy |
4,084
+3,022
| +285% | +$245K | ﹤0.01% | 967 |
|
2024
Q4 | $95.6K | Buy |
1,062
+538
| +103% | +$48.5K | ﹤0.01% | 1059 |
|
2024
Q3 | $51.8K | Buy |
+524
| New | +$51.8K | ﹤0.01% | 1053 |
|
2024
Q2 | – | Sell |
-857
| Closed | -$71.5K | – | 1051 |
|
2024
Q1 | $71.5K | Sell |
857
-2,306
| -73% | -$193K | ﹤0.01% | 689 |
|
2023
Q4 | $282K | Sell |
3,163
-3,718
| -54% | -$332K | ﹤0.01% | 577 |
|
2023
Q3 | $502K | Buy |
6,881
+1,020
| +17% | +$74.5K | 0.01% | 332 |
|
2023
Q2 | $488K | Sell |
5,861
-15,089
| -72% | -$1.26M | 0.01% | 279 |
|
2023
Q1 | $1.6M | Buy |
20,950
+2,254
| +12% | +$172K | 0.03% | 169 |
|
2022
Q4 | $1.55M | Sell |
18,696
-7,332
| -28% | -$609K | 0.03% | 176 |
|
2022
Q3 | $2.07M | Buy |
26,028
+2,446
| +10% | +$194K | 0.04% | 156 |
|
2022
Q2 | $1.75M | Buy |
23,582
+3,742
| +19% | +$278K | 0.04% | 182 |
|
2022
Q1 | $1.78M | Sell |
19,840
-10,371
| -34% | -$932K | 0.03% | 190 |
|
2021
Q4 | $3.38M | Buy |
+30,211
| New | +$3.38M | 0.05% | 139 |
|
2014
Q2 | – | Sell |
-153
| Closed | -$7K | – | 1636 |
|
2014
Q1 | $7K | Buy |
+153
| New | +$7K | ﹤0.01% | 1500 |
|